Dr. Jay Fishleder

Dr. Sun is an expert in both pediatric neurology and cerebrovascular neurology, with a special interest in pediatric and young adult stroke. She focuses on both acute care of stroke as well as longitudinal management of an array of neurologic conditions that affect children and young adults. Dr. Sun’s research focuses broadly on pediatric and young adult stroke, with emphasis on discovering the causes, treatments, and prevention of stroke in the young. More specifically, Dr. Sun is investigating novel monitoring and stroke prevention techniques in children with moyamoya disease, which is a rare disease that places affected children and young adults at high risk of stroke. The goal of Dr. Sun's research is to improve outcomes and quality of life of individuals affected by stroke and moyamoya disease. In addition to her clinical and research interests, Dr. Sun is the associate program director of the Child Neurology residency program at Johns Hopkins. After completing medical school at the Johns Hopkins University School of Medicine, Dr. Sun completed her pediatrics and neurology residency training at Johns Hopkins, and subsequently she completed a fellowship in Vascular Neurology/Stroke. Dr. Sun is rated as an Advanced provider by MediFind in the treatment of Moyamoya Disease. Her top areas of expertise are Moyamoya Disease, Stroke, Stiff Person Syndrome, Thrombectomy, and Cerebral Artery Bypass Surgery.

Saqib Chaudhry is a Neurologist in Alexandria, Virginia. Dr. Chaudhry is rated as a Distinguished provider by MediFind in the treatment of Moyamoya Disease. His top areas of expertise are Stroke, Brain Aneurysm, Subarachnoid Hemorrhage, Stent Placement, and Carotid Artery Surgery. Dr. Chaudhry is currently accepting new patients.

Reza Kanani is a Neurologist in Columbia, Maryland. Dr. Kanani is rated as a Distinguished provider by MediFind in the treatment of Moyamoya Disease. His top areas of expertise are Cervical Myelopathy, Spinal Tumor, Brain Stem Cancer, and Dysembryoplastic Neuroepithelial Tumors (DNET).